The effect of cytotoxic agents on autophagic vacuole formation in chloroquine-treated malaria parasites (Plasmodium berghei).
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001377:Azaserine / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use*; D003078:Colchicine / Q000627:therapeutic use; D003513:Cycloheximide / Q000008:administration & dosage; D003593:Cytoplasm / Q000187:drug effects*; D003609:Dactinomycin / Q000008:administration & dosage; D008288:Malaria / Q000188:drug therapy*; D015122:Mercaptopurine / Q000008:administration & dosage; D051379:Mice; D008937:Mitomycins / Q000627:therapeutic use; D009696:Nucleic Acids / Q000096:biosynthesis; D010860:Pigments, Biological; D010961:Plasmodium / Q000187:drug effects*; D014176:Protein Biosynthesis; D012270:Ribosomes / Q000378:metabolism; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D008937:Mitomycins; D009696:Nucleic Acids; D010860:Pigments, Biological; D003609:Dactinomycin; D014498:Uracil; D001377:Azaserine; D002738:Chloroquine; D003513:Cycloheximide; D015122:Mercaptopurine; D003078:Colchicine